Close
Novotech
Jabsco PureFlo 21 Single Use

Boston Analytical Continues Expansion with Office in Cambridge MA

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

eschbach Unveils Shiftconnector Activity Scheduler

New feature helps pharma manufacturing teams streamline daily production...

Smart Inspection Systems with HV Leak Detection Technology

The convergence of digital transformation and precision engineering has given rise to a new generation of quality control in pharmaceutical manufacturing. Smart inspection systems with HV leak detection technology utilize advanced sensors and real-time data analytics to identify microscopic structural flaws in sterile packaging with unprecedented accuracy. By automating the detection of leaks that are invisible to the human eye, these intelligent systems significantly enhance the reliability of the manufacturing process, ensuring that every container meets the highest standards of safety and sterility.

Clinical Trial Patient Recruitment and Site Selection

Maximizing the speed and quality of drug development requires a data-driven approach to patient enrollment and site identification, where precision analytics meet operational excellence in the 2026 clinical landscape.
- Advertisement -

Boston Analytical, a leading provider of analytical and microbiological testing to the pharmaceutical industry, has opened an office in downtown Cambridge. This expansion comes two years after opening a 30,000 square foot, state-of-the-art facility in Salem, NH, and one year after opening a 5,000 square foot laboratory specifically for its ever growing protein characterization services.

This move is a logical expansion for Boston Analytical, which has experienced double-digit growth over the past five years. The new location is in the heart of the Cambridge Life Sciences Corridor, a geography occupied by hundreds of life science companies. Kristin Dangelo, Director of Business Development, noted, “The Cambridge office provides Boston Analytical proximity to many of the organizations we serve.”

The new office is located at 1 Broadway Street. This location offers many amenities to a highly educated work force, and is an easy commute from Boston Analytical’s facility in Salem, New Hampshire.

About Boston Analytical: Boston Analytical, the Life Sciences division of Alpha Analytical, is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2005 certified analytical laboratory located in Salem, NH. Boston Analytical provides testing services to Pharmaceutical and Medical Device companies worldwide including Analytical Testing and Method Development, Protein Chemistry Studies, Microbiological Testing and EM Services, Stability Testing & ICH-compliant Storage, and Extractables & Leachables Studies.

Latest stories

Related stories

eschbach Unveils Shiftconnector Activity Scheduler

New feature helps pharma manufacturing teams streamline daily production...

Smart Inspection Systems with HV Leak Detection Technology

The convergence of digital transformation and precision engineering has given rise to a new generation of quality control in pharmaceutical manufacturing. Smart inspection systems with HV leak detection technology utilize advanced sensors and real-time data analytics to identify microscopic structural flaws in sterile packaging with unprecedented accuracy. By automating the detection of leaks that are invisible to the human eye, these intelligent systems significantly enhance the reliability of the manufacturing process, ensuring that every container meets the highest standards of safety and sterility.

Clinical Trial Patient Recruitment and Site Selection

Maximizing the speed and quality of drug development requires a data-driven approach to patient enrollment and site identification, where precision analytics meet operational excellence in the 2026 clinical landscape.

Kindeva® commemorates 70 years of pMDI Innovation

Kindeva® commemorates 70 years of the pMDI as inventors...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »